Price
$45.80-15.54%Social Signal Score
Analyst Ratings
29 analysts52-week range
- Last close
- $45.80
- Off 52w high
- -17.8%
- 200-day average
- $47.11
- vs 200-day
- -2.8%
Revenue
$18.85B+113.62%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sergio Ermotti
- Sector
- Financial Services
- Industry
- Banks - Diversified
- Employees
- 103,177
- Beta
- 0.83
- Country
- CH
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- -0.26
Financials
Revenue
$18.85B+113.6%Net Income
$2.61B+122.6%EBITDA
$4.32B+1543.8%Free Cash Flow
—EPS (diluted)
$0.83+388.2%Shares Outstanding (diluted)
3.16B-17.3%Operating Expenses
$6.51BCash & Debt
$354.69BReturn of Capital
$0.00Dividend per Share
$1.10Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $73.84B | $7.77B | $2.46 |
| 2024 | $84.56B | $5.08B | $1.59 |
| 2023 | $79.76B | $27.85B | $8.83 |
| 2022 | $41.13B | $7.63B | $2.34 |
| 2021 | $38.65B | $7.46B | $2.14 |
| 2020 | $37.33B | $6.56B | $1.83 |
| 2019 | $35.47B | $4.22B | $1.14 |
| 2018 | $36.85B | $4.48B | $1.17 |
| 2017 | $35.78B | $0.00 | $0.25 |
| 2016 | $36.91B | $0.00 | $0.90 |
| 2015 | $36.49B | $0.00 | $1.66 |
| 2014 | $32.81B | $3.42B | $0.87 |
| 2013 | $35.74B | $0.00 | $0.94 |
| 2012 | $36.44B | $0.00 | $-0.73 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $3.59
- Implied price
- $68.20
- Return from $43.32
- 9.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $33.91 — -21.7% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| -2.0% | -7.9% | -4.0% | -0.6% | 2.3% | 5.0% |
| 3.0% | -3.2% | 0.9% | 4.4% | 7.5% | 10.3% |
| 8.0% | 1.5% | 5.8% | 9.5% | 12.8% | 15.7% |
| 13.0% | 6.2% | 10.7% | 14.6% | 18.0% | 21.0% |
| 18.0% | 10.9% | 15.6% | 19.6% | 23.2% | 26.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50-20.00%Social Signal Score
Mentions (100)
- Newsmarketbeat.com·5h ago·Neutral
UBS Group to Unveil Post-Credit Suisse Strategy, Capital and Buyback Priorities in February UBS Group NYSE: UBS expects to outline its post-integration strategy in February, including its capital ratio target, return ambitions and priorities for allocating capital between growth and shareholder distributions, Group Chief Financial Officer Todd Tuckner said.
View source ↗ - Newsproactiveinvestors.com·3d ago·Positive
Nvidia faces 2028 growth concerns as UBS cuts price target to US$220 UBS has cut its price target on Nvidia Corp (NASDAQ:NVDA, XETRA:NVD), the semiconductor maker, by 8% to US$220 from US$240, while retaining its 'buy' rating. The revised valuation reflects concerns about slowing growth in calendar 2028, despite strong near-term demand and improving revenue visibility.
View source ↗ - Newsprnewswire.com·3d ago·Negative
AT&T to Webcast Fireside Chat with John Stankey at the UBS Global Media and Communications Conference on Dec. 8 Fireside chat begins at 8:15 a.m. ET and will be available live and for replay on the AT&T Investor Relations website At-a-glance What is being announced?
View source ↗ - Newskitco.com·3d ago·Positive
Gold adds resilience despite near-term headwinds, copper will hit $15,500/t in 2027 – UBS Gold is an important part of any investor portfolio, and while the yellow metal currently faces headwinds from high yields and the expectation of further Fed hikes, gold and other commodities still help mitigate fiscal, monetary, and geopolitical risk, according to Sagar Khandelwal, investment strategist at UBS.In a new analysis published Wednesday, Khandelwal wrote that investors should maintain long-term …
View source ↗ - Newsbusinesswire.com·3d ago·Neutral
Versigent CFO to Participate in UBS Global Industrials and Transportation Conference on December 2 SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low- and high-voltage electrical architectures, today announced Chief Financial Officer, Doug Ostermann will participate in a fireside chat at the UBS Global Industrials and Transportation Conference on Wednesday, December 2, 2026, at 11:20 a.m. ET.The live webcast will be availa…
View source ↗ - Newsseekingalpha.com·4d ago·Positive
Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript
View source ↗ - Newsprnewswire.com·4d ago·Neutral
CPKC's President and CEO Keith Creel to address the 2026 UBS Global Industrials and Transportation Conference CALGARY, AB, Nov. 18, 2026 /PRNewswire/ -- Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) President and Chief Executive Officer Keith Creel will address the 2026 UBS Global Industrials and Transportation Conference on Dec. 1, 2026, at 8:00 a.m. ET. CPKC will provide access to the live audio webcast at investor.cpkcr.com.
View source ↗ - Newszacks.com·4d ago·Positive
Following Goldman Sachs & UBS? Bet on S&P 500 ETFs for 2027 Goldman Sachs and UBS see further upside for the S&P 500 in 2027. Explore these ETFs to capture the potential rally.
View source ↗ - Newsinvezz.com·4d ago·Positive
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI UBS expects US stocks to deliver another year of gains in 2027, forecasting that the benchmark S&P 500 will climb to 8,200 by the end of the year as resilient economic growth and stronger corporate earnings support equities. However, the investment bank has also warned that the artificial intelligence boom could face a difficult phase as infrastructure investments accelerate faster than the revenue they generate.
View source ↗ - Newsseekingalpha.com·5d ago·Positive
Damora Therapeutics, Inc. (DMRA) Presents at UBS Global Biopharma Conference 2026 Transcript Damora Therapeutics, Inc. (DMRA) Presents at UBS Global Biopharma Conference 2026 Transcript
View source ↗ - Newsreuters.com·5d ago·Neutral
UBS set to accept defeat over Swiss capital curbs, sources say UBS set to accept defeat over Swiss capital curbs, sources say
View source ↗ - Newsprnewswire.com·6d ago·Neutral
TI CEO Haviv Ilan to speak at UBS investor conference Dec. 1, 2026, 10:15 a.m. Mountain time DALLAS, Nov. 16, 2026 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) Chairman, President and Chief Executive Officer Haviv Ilan will speak at the UBS Global Technology and AI Conference in Scottsdale, Arizona, on Tuesday, Dec. 1, at 10:15 a.m.
View source ↗ - Newsseekingalpha.com·6d ago·Positive
ADARx Pharmaceuticals, Inc. (ADRX) Presents at UBS Global Biopharma Conference 2026 Transcript ADARx Pharmaceuticals, Inc. ( ADRX ) UBS Global Biopharma Conference 2026 November 16, 2026 9:00 AM EST Company Participants Li Zhen - Co-Founder, President, CEO & Director Conference Call Participants Michael Yee - UBS Investment Bank, Research Division Presentation Michael Yee UBS Investment Bank, Research Division All right. Thank you, everyone.
View source ↗ - Newsseekingalpha.com·6d ago·Positive
Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 Transcript Jade Biosciences, Inc. ( JBIO ) UBS Global Biopharma Conference 2026 November 16, 2026 7:00 AM EST Company Participants Tom Frohlich - President, CEO & Director Andrew King - President of Research & Development Conference Call Participants Michael Yee - UBS Investment Bank, Research Division Presentation Michael Yee UBS Investment Bank, Research Division All right. I get to say good afternoon.
View source ↗ - Newsbusinesswire.com·9d ago·Neutral
Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026 WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will participate in a fireside chat hosted by UBS on Thursday, November 19th, at 8:30 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fi…
View source ↗ - Newsfool.com·9d ago·Positive
UBS Thinks Rivian Stock Can Hit $17. Is It a Buy? Rivian (RIVN -5.46%) has a potential breakthrough in its R2 SUV and UBS sees upside to $17 per share as production improves, with software revenue supporting the business. But with free cash flow deeply negative, the critical question is whether stronger vehicle margins can arrive fast enough to turn this promising growth story into a sustainable business.
View source ↗ - Newsseekingalpha.com·11d ago·Positive
BillionToOne, Inc. (BLLN) Presents at 2026 UBS Global Healthcare Conference Transcript BillionToOne, Inc. ( BLLN ) 2026 UBS Global Healthcare Conference November 10, 2026 2:00 PM EST Company Participants Oguzhan Atay - Co-Founder, Chairman & CEO Presentation Unknown Analyst Good afternoon. I'm Doug Schenkel with UBS, and it's my pleasure to welcome Oguzhan Atay, Co-Founder and Chief Executive Officer of BillionToOne.
View source ↗ - Newsseekingalpha.com·12d ago·Positive
Shoulder Innovations, Inc. (SI) Presents at 2026 UBS Global Healthcare Conference Transcript Shoulder Innovations, Inc. ( SI ) 2026 UBS Global Healthcare Conference November 10, 2026 3:30 PM EST Company Participants Robert Ball - Executive Chairman, CEO & President Conference Call Participants Patrick Andrew Wood - UBS Investment Bank, Research Division Presentation Patrick Andrew Wood UBS Investment Bank, Research Division All right. Amazing. Well, thank you so much, and welcome, everybody.
View source ↗ - Newsseekingalpha.com·12d ago·Positive
Strata Critical Medical, Inc. (SRTA) Presents at 2026 UBS Global Healthcare Conference Transcript Strata Critical Medical, Inc. (SRTA) Presents at 2026 UBS Global Healthcare Conference Transcript
View source ↗ - Newsfool.com·13d ago·Positive
UBS: 3 Key Takeaways for Long-Term Investors UBS repurchased $4.8 billion of shares year to date. Global Wealth Management attracted $55 billion in inflows.
View source ↗ - Newsglobenewswire.com·13d ago·Neutral
ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (Nasdaq: ADRX), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, today announced that Zhen Li, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the UBS Global Biopharma Conference in London, UK on Monday, November 16, at 2:00 p.m.
View source ↗ - Newsreuters.com·14d ago·Neutral
UBS CEO says AI investors had been pricing for 'perfection' until sector's sharp correction UBS CEO says AI investors had been pricing for 'perfection' until sector's sharp correction
View source ↗ - Newsglobenewswire.com·16d ago·Neutral
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET.
View source ↗ - Newsnypost.com·16d ago·Neutral
The latest twist in the saga between UBS and Swiss regulators involves bank's New York business Wall Street tongues are wagging that the bank could finally ditch its UBS Americas unit.
View source ↗ - Newsreuters.com·17d ago·Neutral
UBS departure would be catastrophic, says Zurich cantonal government president UBS departure would be catastrophic, says Zurich cantonal government president
View source ↗ - Newsprnewswire.com·18d ago·Neutral
Labcorp to Speak at the UBS Global Healthcare Conference BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10 at 8:45 a.m.
View source ↗ - Newsprnewswire.com·19d ago·Neutral
Elanco to Participate in UBS Global Healthcare Conference INDIANAPOLIS, Nov. 3, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the UBS Global Healthcare Conference on November 9, 2026. Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital Transformation will participate in a fireside chat on Monday, November 9 at 1:15 p.m.
View source ↗ - Newsglobenewswire.com·19d ago·Neutral
Cardiff Oncology to Participate in the UBS Global Biopharma Conference SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present and participate in 1x1 investor meetings at the UBS Global Biopharma Conference on November 16-17, 2026.
View source ↗ - Newsfool.com·20d ago·Positive
Stock Market Today, Nov. 2: Rivian Rallies on UBS Upgrade and Solid R2 Demand Outlook NASDAQ · As of 4:00 PM ET 11/02/26
View source ↗ - Newsinvezz.com·20d ago·Positive
Rivian stock jumps 10%, here's why Rivian Automotive (RIVN) stock gained on Monday after UBS upgraded the electric-vehicle maker to Buy from Hold, citing improving demand prospects for its R2 models and the potential for higher automotive gross margins. UBS analyst Joseph Spak maintained his $17 price target, pointing to valuation and the potential for an improvement in Rivian's business as production of its lower-priced R2 vehicles increases.
View source ↗ - Newszacks.com·20d ago·Neutral
UBS Boosts Profitability Ambitions as Cost Savings Exceed Expectations UBS Group reports 16.7% underlying ROCET1 in Q3'26 and expects to exceed its 2026 profitability target, supported by revenue growth and cost savings.
View source ↗ - News247wallst.com·20d ago·Neutral
Rivian Climbs 4% as UBS Upgrade Bets on R2 Ramp; Lucid and Tesla Edge Higher A fresh analyst upgrade is lifting Rivian Automotive (NASDAQ:RIVN | RIVN Price Prediction). The stock is posting a second straight gain as Wall Street warms up to the electric vehicle (EV) maker's lower-priced R2 SUV.
View source ↗ - Newsfool.com·20d ago·Neutral
UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case. UBS sees approximately 250% upside potential for Viking shares over the next year. Viking's weight loss candidates could compete effectively with the established drugs from Eli Lilly and Novo Nordisk.
View source ↗ - Newsglobenewswire.com·24d ago·Neutral
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026 SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming UBS Global Healthcare Conference in Palm Beach Gardens, FL. Management will be hosting a fireside chat on Tuesday, November 10, 2026, at 2:00 p.m. Pacifi…
View source ↗ - Newsseekingalpha.com·24d ago·Neutral
UBS Reaffirmed As Buy After Q3 Results Impress, Credit Suisse Integration Progresses UBS Group gets prior buy rating reaffirmed, agreeing with Wall St consensus, after Q3 results came out this week. Top and bottom-line results were impressive, despite the missed earnings estimate, and forward consensus EPS growth is strong. The firm is A-level investment-grade with modest D/E and a CET1 ratio well above regulatory minimums.
View source ↗ - Newsbusinesswire.com·24d ago·Neutral
Qnity to Present at the UBS Global Technology and AI Conference WILMINGTON, Del.--(BUSINESS WIRE)--Qnity Electronics, Inc. (“Qnity”) (NYSE: Q), a premier technology solutions leader across the semiconductor value chain, today announced that Jon Kemp, Qnity's Chief Executive Officer will present at the UBS Global Technology and AI Conference on December 2, at 2:15 p.m. MT. A live webcast of the presentation will be available at Events | Qnity Electronics, Inc. (Q). A replay of the webcast will be…
View source ↗ - Newszacks.com·25d ago·Negative
Is the Options Market Predicting a Spike in UBS Stock? Investors need to pay close attention to UBS stock based on the movements in the options market lately.
View source ↗ - Newszacks.com·25d ago·Negative
UBS (UBS) Q3 Earnings Miss Estimates UBS (UBS) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.76 per share a year ago.
View source ↗ - Newsmarketbeat.com·25d ago·Neutral
UBS Group Q3 Earnings Call Highlights UBS Group NYSE: UBS reported third-quarter 2026 net profit of $2.7 billion, or $0.85 per share, as gains across its core businesses and continued Credit Suisse integration savings supported revenue growth that outpaced expenses.
View source ↗ - Newsyoutube.com·25d ago·Neutral
UBS CEO Ermotti on Earnings, Cost Savings, Capital Return Plans UBS CEO Sergio Ermotti speaks to Bloomberg's Stephen Carroll after the lender posted third-quarter profit broadly in line with expectations, with a surge in client inflows potentially buoying the outlook for the global wealth manager. The Zurich-based bank said net income in the three months through September was $2.69 billion, while net new assets in the wealth unit came in at $55.1 billion, led by Asia Pacific and the Americas.
View source ↗ - Newswsj.com·25d ago·Neutral
UBS Profit Climbs as Wealth-Management Inflows Increase UBS Group reported a rise in third-quarter net profit, boosted by growth in its wealth-management platform.
View source ↗ - Newscnbc.com·25d ago·Neutral
UBS pre-tax profits jump 27% to $3.59 billion in the third quarter UBS pre-tax profits jump 27% to $3.59 billion in the third quarter
View source ↗ - Newsbusinesswire.com·25d ago·Positive
UBS reports 3Q26 net profit of USD 2.7bn and 14.8% RoCET1, continued strong client momentum and disciplined execution across businesses (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules) ZURICH--(BUSINESS WIRE)--Regulatory News: UBS (NYSE:UBS) (SWX:UBSN): “In an increasingly complex market environment, our strong third-quarter performance once again demonstrated the benefits of our diversified global business model and disciplined execution.“ “The breadth a…
View source ↗ - Newsbusinesswire.com·26d ago·Neutral
Butterfly Network to Present at UBS Global Healthcare Conference on November 10, 2026 NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, cloud software and AI, today announced that it will attend the UBS Global Healthcare Conference in Palm Beach Garden, FL on November 10, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief F…
View source ↗ - Newsglobenewswire.com·27d ago·Positive
Clover Health to Participate in Upcoming UBS Global Healthcare Conference WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 12:30 p.m.
View source ↗ - Newsschaeffersresearch.com·27d ago·Positive
UBS Sees More Upside for Ross Stores Stock Ross Stores Inc (NASDAQ:ROST) stock is up 3.4% at $237.17 this morning, after UBS upgraded the discount retailer to "buy" from "neutral" and raised its price target to $315 from $239.
View source ↗ - Newsreuters.com·28d ago·Negative
Employees group warns of major Swiss job losses if UBS relocates, newspaper says Employees group warns of major Swiss job losses if UBS relocates, newspaper says
View source ↗ - Newszacks.com·32d ago·Neutral
UBS (UBS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release UBS (UBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
View source ↗ - Newsreuters.com·34d ago·Neutral
UBS capital rules have Swiss stuck between a rock and a hard place UBS capital rules have Swiss stuck between a rock and a hard place
View source ↗ - Newsproactiveinvestors.com·37d ago·Neutral
Signet's reported De Beers bid fits natural diamond strategy, UBS says Signet Jewelers Limited (NYSE:SIG)'s potential involvement in a consortium seeking to acquire De Beers is aligned with its natural diamond strategy, UBS analysts wrote in a note. Natural diamonds made up about 40% of Signet's calendar 2025 sales, according to analysts.
View source ↗ - Newsproactiveinvestors.com·37d ago·Positive
Procter & Gamble's improving US sales trends set up a favorable first-quarter report, UBS says Procter & Gamble Co (NYSE:PG, XETRA:PRG) is expected to show stronger sales momentum when it reports fiscal first-quarter 2027 results before the market opens on October 22, according to UBS. The brokerage kept its Buy rating and $172 price target, saying improving top-line trends should be enough to drive outperformance.
View source ↗ - Newsproactiveinvestors.com·37d ago·Neutral
Six Flags price target cut at UBS after Georgia coaster death, but bank sees market overstating impact Six Flags Entertainment (NYSE:SIX) may face a smaller financial hit from the fatal Georgia coaster accident than the market is pricing in, UBS said as it lowered its price target to $18 from $27. A 42-year-old guest was ejected from the Goliath coaster at Six Flags Over Georgia on Oct. 12, and other guests were injured.
View source ↗ - Newsinvezz.com·37d ago·Negative
UBS share price flashes a warning pattern as capital rules force tough choices UBS shares have entered a technical correction, falling more than 12% from their high for the year. The stock dropped to 39 francs after peaking at 45 francs in August.
View source ↗ - Newsproactiveinvestors.com·38d ago·Neutral
Chipotle faces near-term sales pressures but UBS sees stronger growth in 2027 UBS expects Chipotle Mexican Grill Inc (NYSE:CMG), the US restaurant chain, to report broadly in-line third-quarter sales on October 28, with sales growth and restaurant margins facing continued pressure before a potential recovery in 2027. The bank forecasts same-store sales growth of 1.5% for the quarter, slightly above the 1.3% consensus estimate, but expects weaker trends at the start of the fourth quarter to chall…
View source ↗ - Newsreuters.com·38d ago·Neutral
UBS extends Fed tightening cycle forecast with March rate hike after inflation surprise UBS extends Fed tightening cycle forecast with March rate hike after inflation surprise
View source ↗ - Newsreuters.com·39d ago·Neutral
UBS weighs moving headquarters from Switzerland if capital rules tighten, WSJ reports UBS weighs moving headquarters from Switzerland if capital rules tighten, WSJ reports
View source ↗ - Newsproactiveinvestors.com·39d ago·Positive
UBS raises BP forecasts as debt set to fall $4 billion below expectations BP PLC's (LSE:BP.) net debt is on course to come in as much as $4 billion below previous estimates, according to UBS, which has a 'buy' rating and a 700p price target on the oil major.
View source ↗ - Newsreuters.com·40d ago·Neutral
Swiss parliamentary committee backs fee on UBS for public liquidity backstop Swiss parliamentary committee backs fee on UBS for public liquidity backstop
View source ↗ - Newsproactiveinvestors.com·40d ago·Neutral
UBS raises Wise price target 12% to 1,300p ahead of results UBS has raised its price target on Wise Group PLC (LSE:WISE, NASDAQ:WSE), the cross-border payments company, to 1,300p from 1,160p, keeping its 'buy' rating, because it expects higher interest rates to lift earnings. The new target is 41.6% above Wise's closing price of 918p on Monday, which valued the company at about £9.41 billion.
View source ↗ - Newsproactiveinvestors.com·44d ago·Positive
SpaceX's low-band spectrum deal gives Starlink Mobile a terrestrial foothold, UBS says SpaceX Corp (NASDAQ:SPCX) is buying 14 MHz of 800 MHz spectrum from Grain Management, giving Starlink Mobile the low-band coverage layer UBS says it needs to build a terrestrial network reaching dense urban areas and building interiors that its satellites cannot. The analysts view low-band spectrum as key because of its superior coverage characteristics.
View source ↗ - Newsproactiveinvestors.com·44d ago·Neutral
Pepsi offers attractive risk-reward despite lowered 2026 outlook, says UBS PepsiCo Inc (NASDAQ:PEP, XETRA:PEP)'s slower-than-expected North America recovery warrants a valuation discount, but UBS says the size of that discount is hard to justify. The food and beverage giant's quarter gave both bulls and bears something to work with.
View source ↗ - Newsfool.com·45d ago·Neutral
UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument. UBS analyst Michael Yee believes investors prefer Eli Lilly's growth story to Novo Nordisk's turnaround story. Yee sees Novo Nordisk turning its business around, but believes it could take some time.
View source ↗ - News247wallst.com·45d ago·Negative
Bloom Energy Tumbles 8% Even as UBS Lifts Its Price Target to $350; FuelCell Energy Slides 8%, Plug Power Drops 3% A raised analyst price target wasn't enough to support Bloom Energy (NYSE:BE) stock, and the selling has spread across fuel cell and hydrogen names. BE stock is at $269.16, down 8% this afternoon.
View source ↗ - Newsproactiveinvestors.com·46d ago·Positive
Skydance gains streaming scale but faces high leverage and TV exposure, UBS says Skydance, the entertainment company formed when Paramount Skydance Corp (NASDAQ:PSKY) merged with Warner Bros Discovery Inc (NASDAQ:WBD, XETRA:J5A) on Tuesday, has the scale to compete in streaming but remains highly leveraged and exposed to traditional television. UBS estimates net leverage, net debt as a multiple of earnings before interest, taxes, depreciation and amortization (EBITDA), at about 6.5 times.
View source ↗ - Newszacks.com·46d ago·Negative
UBS to Deepen NTRS Tie-Up With Credit Suisse Fund Administration Deal UBS Group is set to transfer former Credit Suisse fund administration businesses to Northern Trust, deepening their partnership while simplifying operations.
View source ↗ - News247wallst.com·46d ago·Positive
UBS Flags a Bullish Setup in Tesla Stock and Lifts Its Price Target UBS analyst Joseph Spak raised his price target on Tesla (NASDAQ:TSLA | TSLA Price Prediction) to $391, according to UBS from $385, according to UBS and kept his Buy rating. The argument behind the modest bump carries the weight.
View source ↗ - Newsproactiveinvestors.com·46d ago·Negative
UBS downgrades Inchcape as weaker volumes cloud near-term outlook UBS has downgraded Inchcape PLC (LSE:INCH), the global automotive distributor, to 'neutral' from 'buy' and cut its price target to 750p from 990p as weaker volumes cloud near-term earnings. UBS analysts Abi Bell, Rory McKenzie and Nicole Manion expect Inchcape's adjusted earnings per share estimates to fall by 2% to 7% between 2026 and 2028 as volumes, product mix and the APAC recovery prove weaker than expected.
View source ↗ - Newsproactiveinvestors.com·46d ago·Negative
UBS cuts Unilever price target as higher finance costs trim earnings view UBS has cut its price target for Unilever PLC (LSE:ULVR), the consumer goods group, to 4,390p from 4,440p after reducing its 2026 earnings forecast by 1%. The bank retained its 12-month 'sell' rating, while Unilever's shares were priced at 4,542p in the research note dated 6 October.
View source ↗ - Newsproactiveinvestors.com·47d ago·Neutral
Delta Air Lines faces high bar for fourth-quarter revenue outlook, UBS says Delta Air Lines Inc (NYSE:DAL) faces a high bar for fourth-quarter revenue growth, with UBS saying investors are focused on whether the airline can offset a potential earnings guidance cut with stronger sales. Investors expect third-quarter revenue growth of about 16% to 16.5%, while expectations for earnings per share range from $1.70 to $1.90, compared with UBS's $1.70 estimate and a $1.94 consensus.
View source ↗ - Newsproactiveinvestors.com·47d ago·Neutral
UBS sees BHP and Rio Tinto leading iron ore quarter as prices hit more than 10-year lows UBS, the Swiss bank, expects BHP Group Ltd (LSE:BHP, ASX:BHP) and Rio Tinto Ltd (LSE:RIO, ASX:RIO, OTC:RTNTF) to deliver stronger iron ore shipments in the September quarter, although weak Chinese demand is keeping prices under pressure. UBS analysts Myles Allsop, Lachlan Shaw and colleagues said iron ore prices had fallen to about $91 a tonne, with free-on-board prices at more than 10-year lows.
View source ↗ - Newsproactiveinvestors.com·47d ago·Neutral
IG Group sell-off is an overreaction, says UBS IG Group Holdings Plc (LSE:IGG), the online trading platform, suffered a 22% share-price fall last Friday (Oct. 2) after cutting its 2026 revenue and EBITDA guidance, but UBS described the sell-off as an overreaction. The bank's analyst Haley Tam and colleagues cut their earnings-per-share forecasts by 13% for 2026 through 2028 and reduced the price target to 1,425p from 1,700p, while retaining a 'buy' rating.
View source ↗ - Newsproactiveinvestors.com·48d ago·Positive
Ferrari gets UBS backing as dealer survey points to resilient demand Ferrari (NYSE:RACE), the Italian sports carmaker, has gained 5% this year while the luxury sector has fallen 23%, and UBS has kept its 'buy' rating on the stock. UBS has cut its price target to $450 from $490 because luxury sector valuations have dropped sharply, not because it expects Ferrari (NYSE:RACE)'s earnings to deteriorate.
View source ↗ - Newsproactiveinvestors.com·48d ago·Neutral
Spotify expected to make progress towards financial targets, UBS says UBS remains constructive on Spotify Technology SA (NYSE:SPOT) and expects the streaming company to continue progressing towards its financial targets despite higher costs from investments in its platform. The Swiss investment bank said Spotify's new products and features should create additional monetization opportunities and improve operating leverage, with the artificial intelligence (AI) Remix tool potentially launching by…
View source ↗ - Newszacks.com·48d ago·Positive
UBS or TD: Which Is the Better Value Stock Right Now? Investors interested in Banks - Foreign stocks are likely familiar with UBS (UBS) and Toronto-Dominion Bank (TD). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - Newswsj.com·52d ago·Positive
UBS Shareholder Calls for Bank to Leave Switzerland U.S. investor Artisan Partners has urged the bank to part ways with its home country over new capital rules.
View source ↗ - Newsreuters.com·52d ago·Neutral
US investor Artisan urges UBS to quit Switzerland over capital rules US asset manager Artisan Partners has urged UBS to leave Switzerland, arguing that proposed tougher capital requirements for the bank are "punitive", excessive and would destroy shareholder value.
View source ↗ - Newsproactiveinvestors.com·54d ago·Positive
SpaceX AI deals drive UBS revenue forecast above consensus SpaceX Corp (NASDAQ:SPCX) is expected to post third-quarter revenue of $13.8 billion, 7% above consensus, with its AI business leading growth, according to UBS. The broker also forecasts adjusted EBITDA of $7.5 billion, up 9% from a consensus of $6.9 billion, alongside growth across all three business segments.
View source ↗ - Newsinvezz.com·54d ago·Positive
Why is SpaceX stock up around 2% today? SpaceX stock SPCX gained 1.7% on Tuesday after UBS said the company's third-quarter results could exceed Wall Street expectations, supported by growth in artificial intelligence, Starlink connectivity, and commercial launches. UBS reiterated a Buy rating on SpaceX and a $210 price target, according to TheFly.
View source ↗ - Newsproactiveinvestors.com·54d ago·Positive
UBS says AI fears overstate threat to RELX as it keeps 3,600p target RELX PLC (LSE:REL), the information and analytics group, has become increasingly disconnected from its improving earnings outlook as concerns over artificial intelligence and autonomous vehicles have pushed its shares down 17% this year. UBS reiterated its ‘buy' rating and 3,600p 12-month price target, arguing that investors have overstated the structural risks to the group's Legal and Risk divisions.
View source ↗ - Newsproactiveinvestors.com·55d ago·Negative
UBS warns BP's US shale ambitions may be premature UBS has questioned the timing of BP PLC (LSE:BP.), the UK-listed energy major, entering data rooms for American shale assets, saying investors want greater progress on debt reduction before fresh spending.
View source ↗ - Newsreuters.com·56d ago·Neutral
Foreign banks have expressed UBS merger interest, Swiss newspaper reports Several major foreign banks have expressed their interest in a possible merger or combination with Switzerland's UBS , a Swiss newspaper said on Sunday.
View source ↗ - Newsreuters.com·57d ago·Neutral
Swiss finance minister says unlikely UBS would leave its home base Switzerland's finance minister said it was unlikely that UBS would leave its Swiss base after this week's upper house parliamentary vote in favour of tougher capital rules.
View source ↗ - Newsbusinesswire.com·58d ago·Neutral
UBS hires Financial Advisors John Pham and Jimmy Yip in Silicon Valley PALO ALTO, Calif. & SAN JOSE, Calif.--(BUSINESS WIRE)--UBS today announced that Financial Advisors John Pham and Jimmy Yip have joined the firm's offices in Palo Alto and San Jose, California. The team joins UBS from Merrill Lynch and will be part of the UBS San Francisco Market, led by Market Executive Emily de la Reguera and reports to Silicon Valley Market Director Jacqueline Kehoe. “We are thrilled to welcome John, Jimmy,…
View source ↗ - Newszacks.com·58d ago·Neutral
UBS Weighs Potential Exit From Switzerland Amid Tougher Capital Rules UBS Group weighs a potential move outside Switzerland through a foreign-bank merger as tougher capital rules could require $16 billion in additional CET1 capital.
View source ↗ - Newsreuters.com·59d ago·Neutral
Swiss lawmakers reflect shift on banks with UBS capital decision A decision by Swiss lawmakers to defy calls by UBS and big business to moderate new banking rules has highlighted misgivings about the risks posed by one of the country's most visible institutions after the 2023 collapse of Credit Suisse.
View source ↗ - Newsbenzinga.com·59d ago·Positive
CoreWeave Trending: A New AI Customer and UBS' Contrarian $120 Call CoreWeave Inc. (NASDAQ:CRWV) is trending Thursday after the company announced a new multi-year customer agreement. UBS initiated coverage of the stock on Wednesday with a Buy rating.
View source ↗ - Newsfool.com·59d ago·Neutral
UBS Says This Bargain Stock Is the "Best AI Enabler in the Market" and Sees Shares Surging 30%+ Following Palantir's latest AIPCon event, UBS analyst Karl Keirstead highlights how the company is enabling AI-driven growth for its customers. Palantir is finally generating faster growth from its commercial segment compared to its legacy government business.
View source ↗ - Newsproactiveinvestors.com·60d ago·Positive
UBS turns bullish on five AI data center stocks UBS has initiated coverage on five AI data center colocation stocks with Buy ratings, citing constrained compute supply and favorable power access positioning the group for rapid growth as AI adoption accelerates. The bank started coverage of Hut 8 Mining Corp (TSX:HUT, Unlisted (US):HUTMF), TeraWulf (NASDAQ:WULF), Applied Digital (NASDAQ:APLD), Core Scientific (NASDAQ:CORZ) and Cipher Digital (NASDAQ:CIFR), pointing to their cryptomining legacies…
View source ↗ - News247wallst.com·60d ago·Neutral
UBS Sees PC Sales Shrinking Again in 2027. Dell and HP Investors Aren't Happy UBS just flipped its 2027 PC outlook from growth to decline, and the fallout hit Dell harder than HP even though HP has far more to lose. The reason comes down to what each stock had already priced in.
View source ↗ - Newsproactiveinvestors.com·60d ago·Positive
Peloton gets to keep 'buy' rating from UBS as it launches cheaper, foldable treadmill Peloton Interactive Inc (NASDAQ:PTON), the connected fitness company, is keeping its 'Buy' rating from UBS with a price target of $10, after the company unveiled three new treadmills. The broker said Peloton's new Tread Flex model, priced at $2,195, was around 33% cheaper than the company's current treadmill, which costs $3,295.
View source ↗ - Newsproactiveinvestors.com·60d ago·Negative
PG&E downgraded by UBS as wildfire reform catalyst fades California utility PG&E Corp (NYSE:PCG) was downgraded to 'neutral' from 'buy' by UBS, which lowered its price target to $14 from $19 as the bank sees a growing risk that California wildfire liability reform will not advance this year. UBS said the likelihood of action on wildfire liability legislation had declined after Governor Gavin Newsom recently discussed a potential special session focused on artificial intelligence (AI) rather than…
View source ↗ - Newsproactiveinvestors.com·60d ago·Neutral
Levi's could raise earnings guidance on stronger topline, UBS says Levi Strauss & Co (NYSE:LEVI) is set for a stronger earnings outlook, according to UBS, which expects better revenue growth to lift the apparel maker's fiscal 2026 earnings guidance and sees further upside if tariff assumptions are lowered. UBS forecasts third-quarter earnings of $0.36 a share, in line with Wall Street expectations, but expects stronger revenue to raise financial 2026 EPS guidance by $0.02 to $1.48-$1.54.
View source ↗ - Newsproactiveinvestors.com·60d ago·Positive
CoreWeave gets 'buy' rating from UBS as AI compute demand strengthens CoreWeave (NASDAQ:CRWV) shares received an initial 'Buy' rating and a $120 price target from UBS, implying about 40% upside, as the bank said strong artificial intelligence (AI) compute demand could support further growth. UBS said Street sentiment towards CoreWeave remained cautious, reflected in a valuation of only about three times expected 2027 revenue despite strong demand signals across the AI infrastructure market.
View source ↗ - Newsbarrons.com·60d ago·Neutral
UBS Says CoreWeave Stock Could Rise Nearly 40% as Debt Fears Ease UBS says CoreWeave's contracts with major customers could help it finance a costly AI data-center expansion.
View source ↗ - Newswsj.com·60d ago·Neutral
Swiss Parliament's Upper House Backs Plan to Ease New Capital Demands on UBS Under the proposal, the bank would be required to hold 90% in top-tier capital against its foreign subsidiaries, down from 100% the government previously planned.
View source ↗ - Newsmarketbeat.com·60d ago·Negative
UBS Warns Swiss Capital Rules Could Cost Billions, Hurt Competitiveness UBS Group NYSE: UBS Chief Executive Officer Sergio Ermotti said proposed Swiss capital rules could impose substantial costs on the bank and create a competitive disadvantage, while also outlining continued progress on the integration of Credit Suisse and growth plans across wealth management.
View source ↗ - Newsreuters.com·61d ago·Neutral
Swiss finance minister and UBS boss face off ahead of capital decision Swiss Finance Minister Karin Keller-Sutter and UBS CEO Sergio Ermotti on Tuesday defended their opposing views on new Swiss capital rules in a last round of appeals before a key parliamentary decision on Wednesday.
View source ↗ - Newsreuters.com·61d ago·Neutral
UBS Ermotti says capital rules will impact Swiss financial centre for decades The political debate on capital rules for UBS will influence the future of the Swiss financial centre for the next decades, UBS CEO Sergio Ermotti said on Tuesday.
View source ↗ - Newsreuters.com·62d ago·Neutral
Swiss business groups pressure parliament over UBS capital rules before vote Swiss business groups have weighed into the debate on tougher capital rules for UBS , writing to lawmakers to lobby against what they say risks being "excessive" regulation drawn up for the bank after the 2023 collapse of Credit Suisse.
View source ↗ - Newsreuters.com·63d ago·Positive
UBS CEO Ermotti warns against harsh capital rules ahead of vote UBS Chief Executive Sergio Ermotti warned lawmakers against imposing excessively strict capital requirements on the Swiss bank in an interview published on Sunday, days before a key parliamentary vote.
View source ↗
Earnings
Wed, Feb 3(in 2 months)
Consensus estimate $0.88 per share
Typical surprise +2.9% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$0.85 vs $0.91miss
- Wed, Jul 29$0.87 vs $0.90miss
- Wed, Apr 29$0.94 vs $0.85beat
- Wed, Feb 4$0.37 vs $0.54miss
- Wed, Oct 29$0.76 vs $0.49beat
- Wed, Jul 30$0.72 vs $0.70beat
Estimates and results for UBS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
- Alan Armstrongsenate · disclosed Jul 21, 2026 (113d later)Buy$15,001 - $50,000
- John R. Curtissenate · UT · disclosed Jun 30, 2026 (28d later)Buy$100,001 - $250,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (32d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 12, 2025 (21d later)Buy$15,001 - $50,000
- Bruce Westermanhouse · AR04 · disclosed May 13, 2025 (22d later)Sell$1,001 - $15,000
- Bruce Westermanhouse · AR04 · disclosed Apr 17, 2025 (45d later)Buy$1,001 - $15,000
- Mikie Sherrillhouse · NJ11 · disclosed Mar 10, 2025 (3d later)Sell$250,001 - $500,000
- Ro Khannahouse · CA17 · disclosed Nov 11, 2024 (40d later)Buy$50,001 - $100,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2024 (17d later)Buy$15,001 - $50,000
- Mikie Sherrillhouse · NJ11 · disclosed May 15, 2024 (1d later)Sell$50,001 - $100,000
- Mikie Sherrillhouse · NJ11 · disclosed May 13, 2024 (0d later)Sell$250,001 - $500,000
- Ro Khannahouse · CA17 · disclosed Oct 6, 2023 (30d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$100,001 - $250,000
- Ro Khannahouse · CA17 · disclosed Mar 8, 2023 (26d later)Buy$15,001 - $50,000
- Mikie Sherrillhouse · NJ11 · disclosed Mar 3, 2023 (0d later)Sell$250,001 - $500,000
- Mikie Sherrillhouse · NJ11 · disclosed May 23, 2022 (0d later)Sell$100,001 - $250,000
- Mikie Sherrillhouse · NJ11 · disclosed Apr 6, 2022 (28d later)Sell$100,001 - $250,000
- Mikie Sherrillhouse · NJ11 · disclosed Dec 3, 2021 (583d later)Sell$100,001 - $250,000
- Mikie Sherrillhouse · NJ11 · disclosed Dec 3, 2021 (550d later)Sell$50,001 - $100,000
- Katherine M. Clarkhouse · MA05 · disclosed Oct 14, 2021 (28d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
